Terminal regions of the Drosophila embryo are patterned by the localized activation of the mitogen-activated protein kinase (MAPK) pathway [1] . This depends on the MAPKmediated downregulation of Capicua (Cic), a repressor of the terminal gap genes [2, 3] . We establish that downregulation of Cic is antagonized by the anterior patterning morphogen Bicoid (Bcd). We demonstrate that this effect does not depend on transcriptional activity of Bcd and provide evidence suggesting that Bcd, a direct substrate of MAPK, decreases the availability of MAPK for its other substrates, such as Cic. Based on the quantitative analysis of MAPK signaling in multiple mutants, we propose that MAPK substrate competition coordinates the actions of the anterior and terminal patterning systems. In addition, we identify Hunchback as a novel target of MAPK phosphorylation that can account for the previously described genetic interaction between the posterior and terminal systems [4] . Thus, a common enzyme-substrate competition mechanism can integrate the actions of the anterior, posterior, and terminal patterning signals. Substrate competition can be a general signal integration strategy in networks where enzymes, such as MAPK, interact with their multiple regulators and targets [5] [6] [7] [8] [9] [10] .
Results and Discussion
Anteroposterior (AP) patterning of the Drosophila embryo depends on three inductive signals [11] : the head and thorax are specified by the anterior gradient of Bicoid (Bcd), a homeobox transcription factor; abdomen formation is directed by the reciprocal gradient of Nanos (Nos), a translational repressor; and the nonsegmented termini are patterned by the localized activation of the extracellular signal-regulated/ mitogen-activated protein kinase (ERK/MAPK) pathway [6, 12] . MAPK signaling is induced by a uniformly expressed receptor tyrosine kinase Torso (Tor), which is activated by its ligand produced at the poles of the embryo [1] .
Activated Tor promotes the expression of tailless (tll) and huckebein (hkb), zygotic gap genes required for the development of the terminal structures. This depends on MAPK-mediated phosphorylation of the transcriptional repressors Capicua (Cic) and Groucho (Gro), both of which are initially distributed uniformly throughout the embryo [1] [2] [3] 13] . Phosphorylation of Cic and Gro relieves their repression of tll and hkb and enables expression of these genes at both poles of the embryo. At the anterior pole, MAPK also phosphorylates Bcd [14, 15] . Thus, MAPK is activated in a localized pattern and phosphorylates substrates that can be either uniformly (Cic and Gro) or nonuniformly (Bcd) distributed along the AP axis of the embryo ( Figures 1A-1C) .
The spatial pattern of MAPK activation can be visualized with an antibody that recognizes the double phosphorylated form of ERK (dpERK) [16, 17] . We found that this pattern is strongly asymmetric: the anterior levels of dpERK are significantly higher than the posterior levels ( Figure 1 ; see also Figure S1 available online). Because the early Drosophila embryo is highly polarized, multiple factors can potentially contribute to the observed asymmetry. These include the differences in the anterior and posterior levels of the extracellular ligand that activates Tor [18] and/or in the intracellular localization of maternal determinants.
We hypothesized that the higher levels of dpERK at the anterior pole reflect the presence of an anteriorly localized maternal factor. One candidate for such a factor is Bcd, which is localized to the anterior of the embryo and is one of the phosphorylation targets of MAPK [14] . To test whether Bcd can affect the AP asymmetry of the dpERK pattern, we examined this pattern in embryos with different levels of Bcd. We found that the anterior levels of dpERK are significantly decreased in embryos from bcd null or heterozygous mothers and increased in embryos with two extra copies of bcd (Figures 2A and 2B) . Importantly, the posterior levels of dpERK are unaffected in these embryos, reflecting the anterior localization of Bcd. Thus, changing the level of Bcd, a substrate of MAPK, influences the level of MAPK phosphorylation.
Previous studies have shown that overexpressing MAPK substrates in a heterologous cell culture system leads to a higher level of MAPK phosphorylation [19] . Furthermore, experiments with purified components revealed that MAPK substrates can directly compete with the MAPK phosphatases for binding to the common docking domain of MAPK [19] [20] [21] [22] [23] . Thus, the level of MAPK substrates can increase the level of MAPK phosphorylation by outcompeting the MAPK phosphatase. Correspondingly, a similar effect can be responsible for the observed dose-dependent control of MAPK phosphorylation levels by Bcd: the total concentration of MAPK substrates at the anterior pole is higher than at the posterior because of the anterior localization of Bcd, resulting in a stronger interference with MAPK dephosphorylation in this region of the embryo. This can account for the higher level of dpERK at the anterior pole. The fact that the anterior level of dpERK is sensitive to the dose of Bcd is consistent with the proposed competition model. This, however, does not exclude the possibility of a more indirect transcriptional effect, whereby one or more transcriptional targets of Bcd would affect the levels of MAPK phosphorylation. To distinguish between these two alternatives, we used the bcd transgene (Bcd-A 9 ), which encodes a Bcd variant that has an impaired ability to bind its DNA recognition sequence [24] but still contains all of the sites required for binding to and phosphorylation by MAPK ( Figure 2C ). We first confirmed that the expression of hunchback (hb), a direct target of Bcd, was not affected in embryos with two copies of wild-type bcd and two copies of the Bcd-A 9 transgene (data not shown). Remarkably, the anterior level of dpERK was significantly increased in these embryos ( Figure 2D ). In fact, the anterior level of dpERK was indistinguishable from the anterior level of dpERK in embryos with two extra copies of wild-type bcd (bcd 4x ). Taken together, these results imply that Bcd can affect the level of MAPK phosphorylation independently of its transcriptional activity.
The results presented so far are consistent with the idea that Bcd makes phosphorylated MAPK less available for binding to and dephosphorylation by the MAPK phosphatase. According to the same model, Bcd can make the phosphorylated MAPK less available for its other substrates. To explore this possibility, we examined the distribution of Cic, which is downregulated at the poles as a result of its direct phosphorylation by MAPK ( Figures 3A-3C ). Statistical analysis revealed that, similar to the wild-type pattern of dpERK, the wild-type pattern of Cic is asymmetrical, with the levels of Cic significantly higher at the anterior pole ( Figure 3D ). Because the distribution of Cic is uniform in the absence of MAPK signaling, the wild-type pattern of Cic downregulation suggests that, although the level of MAPK phosphorylation is higher at the anterior pole, its activity directed toward Cic is actually lower.
We emphasize that this observation argues against the possibility that the AP asymmetry of the wild-type MAPK phosphorylation pattern is generated only by the asymmetry in the extracellular activation of Tor. If this were true, then higher levels of MAPK phosphorylation at the anterior pole would lead to a higher level of Cic downregulation, which is contrary to what we observed. Based on this, we argue that the AP asymmetry of the wild-type MAPK signaling pattern is generated mainly by the intracellular asymmetries of the early embryo. Upon quantifying the spatial pattern of Cic downregulation in embryos with varying levels of Bcd, we established that this asymmetry is increased in embryos with an extra copy of bcd and reduced in embryos with progressively lowered levels of bcd ( Figure 3E ). These effects are consistent with the model, in which anteriorly localized Bcd acts as a competitive inhibitor of MAPK-mediated Cic downregulation.
If Bcd is the only source of the AP asymmetries of MAPK phosphorylation and Cic downregulation, then both of these patterns should become symmetric in bcd null embryos. Surprisingly, however, we found that both MAPK phosphorylation and Cic downregulation exhibited a significant amount of AP asymmetry even in the bcd mutant embryos ( Figures 4A  and 4B ). It is possible that this residual asymmetry reflects the presence of an additional MAPK substrate that is nonuniformly distributed in bcd null embryos and contributes to the AP asymmetry of MAPK signaling in this genetic background.
One candidate for this residual asymmetry is Hunchback (Hb), a transcription factor that plays a key role in the embryonic AP patterning [25, 26] . The distribution of Hb protein depends on both maternal and zygotic inputs [25, 27] . Briefly, (E) Histogram of the ratios of anterior to posterior peak levels of MAPK phosphorylation from 244 wild-type embryos. Individual peak values of dpERK at the termini are determined as described in Figure S1 . In wild-type embryos, this ratio has a mean of 1.87 and a standard deviation of 0.64, which indicates that the anterior levels of dpERK are significantly higher than the posterior levels (t test, p < 10 25 ).
maternal hb transcript is deposited uniformly, but its translation is repressed in the posterior region of the embryo by Nos, resulting in an anterior gradient of maternal Hb protein.
In the anterior half of the embryo, hb is also zygotically activated by Bcd, providing an additional gradient of zygotic Hb protein ( Figure 4C ). As a consequence of its dual control by Bcd and Nos, the pattern of Hb protein is not symmetric in bcd null embryos: the levels of Hb are still higher at the anterior pole. This led us to test whether, similar to Bcd and Cic, Hb acts as a hitherto-unrecognized MAPK substrate that modulates the patterns of MAPK phosphorylation and Cic downregulation along the AP axis. Indeed, in a proteomics screen aimed at identifying potential MAPK substrates in the early blastoderm embryo, we found that Hb is phosphorylated by MAPK in vitro. Like Bcd and Cic, but unlike Runt and other segmentation gene products, Hb displays a MAPK-dependent electrophoretic mobility shift on SDS polyacrylamide gel electrophoresis (SDS-PAGE) ( Figure 4D ; data not shown). To test whether Hb can affect the level of MAPK phosphorylation in vivo, we examined MAPK phosphorylation in embryos with uniform maternal expression of Hb. We found that Hb expression leads to a statistically significant increase in the posterior dpERK signal, as would be expected if Hb was acting as a MAPK substrate in the early embryo ( Figure 4E ). To summarize, the proposed substrate competition model accounts for the experimentally observed AP asymmetry of the wild-type patterns of MAPK phosphorylation and the activity toward its substrates, predicts how this asymmetry responds to multiple genetic perturbations, and identifies Hb as a novel potential target of MAPK phosphorylation. In addition, the proposed model can account for the previously unexplained genetic interaction between the posterior and terminal systems. It was established that removal of posterior patterning determinants (Nos or Oskar [Osk]) increases the posterior level of Cic and consequently reduces the posterior expression domains of its targets, tll and hkb [4] . In light of our results, these effects can be interpreted by the fact that, in nos 2 or osk 2 embryos, ectopic Hb acts as a competitive substrate of MAPK, reducing its ability to downregulate Cic. This would be analogous to the effect at the anterior pole, where downregulation of Cic is antagonized by Bcd. In partial confirmation of this model, we found that removal of either nos or osk increases the posterior level of dpERK, indicating that increased amounts of Hb, like Bcd, can influence the level of MAPK phosphorylation ( Figure 4F ). Thus, a common substrate competition mechanism can provide a basis for the modulation of MAPK signaling by the anterior and posterior systems. Going beyond the early fruit fly embryo, we propose that competitive interactions can provide a general control strategy in signaling networks where enzymes, such as MAPK, interact with their multiple regulators and targets [5-9, 19, 28-35] .
Experimental Procedures

Drosophila Strains and Whole-Mount Immunostaining
The following stocks were used in this study: histone-GFP (a gift from E. Wieschaus), bcd E1 , bcd 4x , osk 6 , nos BN , Cic-HA; cic 1 [3] , Cic-HA; cic
, UAS-hb (a gift from N. Dostatni), and Bcd-A 9 [24] . All flies were raised and embryos were collected at 25 C. Antibody stainings were performed as described in [17] . Monoclonal mouse anti-dpERK (1:100, Sigma) and polyclonal rabbit anti-HA (1:500, Roche) were used as primary antibodies. Alexa Fluor and Oregon green (1:500, Invitrogen) were used as secondary antibodies. 
Microscopy and Image Processing
Imaging was done on a Zeiss LSM510 confocal microscope, with a Zeiss 203 (NA 0.6) A-plan objective. High-resolution images (512 3 512 pixels, 12 bits depth) were obtained from the focal plane in the midhorizontal cross section of the embryo. Images of individual embryos were automatically extracted from raw confocal images and reoriented for gradient quantification, as described elsewhere [17] .
In Vitro MAPK/ERK2 Phosphorylation Assays Proteins were synthesized and labeled with the Quick TNT-coupled rabbit reticulocyte lysate system (Promega) in the presence of [35S]-methionine. Labeled proteins were then incubated with (or without) 0.2 mg of active ERK2, in a total volume of 50 ml of kinase reaction buffer (20 mM HEPES, 0.1 mM benzamidine, 25 mM beta-glycerophosphate, 0.1 mM DTT, 1 mM Na 3 VO 4 , 10 mM MgCl 2 , and 0.1 mM ATP) for 30 min at 30 C. Reactions were stopped by adding SDS sample buffer 33 (0.25 M Tris pH 6.8, 6% SDS, 30% glycerol, B-mercapto-ethanol, and a few grains of Bromophenol-blue). The phosphorylation state of the proteins was subsequently analyzed by SDS-PAGE and autoradiography. To activate ERK2, we expressed a HIS-tagged ERK2 fusion protein in Escherichia coli, purified it on nickel beads (QIAGEN), and activated it with active MEK1 (Upstate).
Statistical Analysis
A paired t test was used to compare the mean levels of both anterior and posterior dpERK between wild-type and mutant embryos of interest. For this analysis, dpERK gradients were extracted from 20-30 wild-type and mutant embryos, and the dpERK levels were determined as described in Figure S1 . To examine the correlation between the amount of Bcd and the level of MAPK phosphorylation, we employed a generalized linear model (GLM) with copies of bcd as the independent variable and either the anterior or posterior dpERK levels as the response variable. Similarly, a GLM was also used to show the correlation between the bcd copy number and the Cic asymmetry, where Cic asymmetry is defined as the ratio of anterior to posterior repressions of Cic, as described in Figure S1 .
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